Clinical Utility of Pharmacogenomic Data Collected by a Health-System Biobank to Predict and Prevent Adverse Drug Events
ConclusionPatients with actionable PGx results from a health-system biobank who received relevant medications experienced predictable ADEs. These ADEs may have been prevented if the patients ’ PGx results were available in the electronic health record with clinical decision support prior to prescribing.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research
More News: Bleeding | Carbamazepine | Coumadin | Drugs & Pharmacology | Electronic Health Records (EHR) | Genetics | Warfarin